...
首页> 外文期刊>Global Challenges >Lopsided Blood‐Thinning Drug Increases the Risk of Internal Flow Choking Leading to Shock Wave Generation Causing Asymptomatic Cardiovascular Disease
【24h】

Lopsided Blood‐Thinning Drug Increases the Risk of Internal Flow Choking Leading to Shock Wave Generation Causing Asymptomatic Cardiovascular Disease

机译:不平衡的血薄药增加内部流量窒息的风险导致引起无症状心血管疾病的冲击波产生

获取原文
           

摘要

The discovery of Sanal flow choking in the cardiovascular‐system calls for multidisciplinary and global action to develop innovative treatments and to develop new drugs to negate the risk of asymptomatic‐cardiovascular‐diseases. Herein, it is shown that when blood‐pressure‐ratio (BPR) reaches the lower‐critical‐hemorrhage‐index (LCHI) internal‐flow‐choking and shock wave generation can occur in the cardiovascular‐system, with sudden expansion/divergence/vasospasm or bifurcation regions, without prejudice to the percutaneous‐coronary‐intervention (PCI). Analytical findings reveal that the relatively high and the low blood‐viscosity are cardiovascular‐risk factors. In vitro studies have shown that nitrogen, oxygen, and carbon dioxide gases are dominant in fresh blood samples of humans/guinea pigs at a temperature range of 98.6–104 F. An in silico study demonstrated the Sanal flow choking phenomenon leading to shock‐wave generation and pressure‐overshoot in the cardiovascular‐system. It has been established that disproportionate blood‐thinning treatment increases the risk of the internal‐flow‐choking due to the enhanced boundary‐layer‐blockage‐factor, resulting from an increase in flow‐turbulence level in the cardiovascular‐system, caused by an increase in Reynolds number as a consequence of low blood‐viscosity. The cardiovascular‐risk can be diminished by concurrently lessening the viscosity of biofluid/blood and flow‐turbulence by raising the thermal‐tolerance‐level in terms of blood‐heat‐capacity‐ratio (BHCR) and/or by decreasing the systolic‐to‐diastolic blood‐pressure‐ratio. It has been shown that at a critical systolic‐to‐diastolic blood‐pressure‐ratio, the internal‐flow‐choking (biofluid/Sanal‐flow‐choking) can occur anywhere in the cardiovascular‐system with or without a plaque or stent. The uneven usage of blood‐thinning drugs increases cardiovascular‐risk because low blood‐viscosity is a risk‐factor for internal‐flow‐choking causing the shock‐wave generation at a critical‐pressure‐ratio.
机译:在心血管系统中发现SALAL流量窒息,呼吁进行多学科和全球行动,以制定创新治疗,并开发新药以否定无症状心血管疾病的风险。在此,表明,当血压比(BPR)达到低临界出血 - 指数(LCHI)内流窒息和冲击波产生时,突然膨胀/发散/血管痉挛或分叉区域,不妨碍皮革冠状动脉干预(PCI)。分析结果表明,相对较高和低血液粘度是心血管危险因素。体外研究表明,氮气,氧和二氧化碳气体在98.6-104 f的温度范围内的新鲜血液样本中占优势,在硅研究中,Silico研究表明了陷阱流动窒息现象导致冲击波心血管系统中的一代和压力过冲。已经确定,不成比例的血薄处理增加了由于增强的边界层阻塞因子而导致内部流动堵塞的风险,由心血管系统中的流动湍流水平的增加导致由于低血液粘度,雷诺数增加。通过在血热容量比(BHCR)方面通过提高热耐受性和/或通过降低收缩量来减少生物流体/血液和流动湍流的粘度,可以通过同时降低生物流体/血液和流动湍流的粘度来减小心血管风险。和/或通过减少收缩量 - 血压 - 压力比。已经表明,在临界收缩到舒张血压 - 血压比下,内部流动窒息(生物流体/肺流量窒息)可以发生或没有斑块或支架的心血管系统中的任何位置发生。血液稀释药的不均匀使用增加了心血管风险,因为低血液粘度是内部流量窒息的风险因素,导致临界压力比的冲击波产生。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号